মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"salveo cg" d.o.o.- podgorica - amantadin - film tableta - 100mg

মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"worwag pharma gmbh &co.kg", boblingen, njemaČka-dio stranog druŠtva podgorica - benfotiamin, piridoksin - obložena tableta - 100mg + 100mg

মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"worwag pharma gmbh &co.kg", boblingen, njemaČka-dio stranog druŠtva podgorica - benfotiamin, piridoksin - obložena tableta - 100mg + 100mg

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

1 a pharma gmbh - rivastigmin - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - simptomatsko liječenje blage do umjereno teške alzheimerove demencije. simptomatsko liječenje blage do umjereno teške demencije kod pacijenata sa idiopatskom parkinsonovom bolešću.

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

amomed pharma gmbh, leopold-ungar-platz 2, beč, austrija - naltreksonklorid - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg naltreksonklorida

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

dr. falk pharma gmbh, leinenweberstraße 5, freiburg, njemačka - budezonid - rektalna pjena - 2 mg - urbroj: 1 potisna doza sadrži 2 mg budezonida

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

dr. falk pharma gmbh, leinenweberstraße 5, freiburg, njemačka - budesonidum - želučanootporne granule - 9 mg - urbroj: svaka vrećica sadrži 9 mg budezonida

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

amomed pharma gmbh, leopold-ungar-platz 2, beč, austrija - naltreksonklorid - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg naltreksonklorida

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

amomed pharma gmbh, storchengasse 1, beč, austrija - landiololum - prašak za otopinu za infuziju - 600 mg - urbroj: svaka bočica sadrži 600 mg landiololklorida što odgovara 560 mg landiolola